Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
By Christina Hernandez Sherwood | Portraits by Jörg Meyer
December 23, 2021
The National Cancer Act, signed into law Dec. 23, 1971, funded the expansion of cancer research and care at Columbia. Today, with plans for a new clinical building, the future looks bright.
Innovation and discovery are at the heart of Herbert Irving Comprehensive Cancer Center's mission to reduce the burden of cancer. Learn more in the HICCC's 2021 annual report.
The new center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
The rate of cervical cancer among women living in neighborhoods with the lowest socioeconomic indices is nearly two times higher than the rate among those who live in areas with the highest indices.
A Columbia study may lead to stomach cancer screening guidelines, especially for Black and Hispanic Americans who have a greater risk of developing or dying from stomach cancer than white Americans.
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.